Notice of Meeting, 27135 [07-2365]
Download as PDF
<![CDATA[
Federal Register / Vol. 72, No. 92 / Monday, May 14, 2007 / Notices
determined by the number of persons
who register at the meeting.
Persons registering to make oral
comments are asked, if possible, to send
a copy of their statement to the
Executive Secretary for the NTP BSC
(see ADDRESSES above) by June 8, 2007,
to enable review by the NTP BSC prior
to the meeting. Written statements can
supplement and may expand the oral
presentation. If registering on-site and
reading from written text, please bring
40 copies of the statement for
distribution to the NTP BSC and NIEHS/
NTP staff and to supplement the record.
Written comments received in response
to this notice will be posted on the NTP
Web site and persons identified by their
name and affiliation and/or sponsoring
organization, if applicable. Persons
submitting written comments should
include their name, affiliation (if
applicable), phone, e-mail, and
sponsoring organization (if any) with
the document.
Background Information on the NTP
Board of Scientific Counselors
The NTP BSC is a technical advisory
body comprised of scientists from the
public and private sectors who provide
primary scientific oversight to the
overall program and its centers.
Specifically, the NTP BSC advises the
NTP on matters of scientific program
content, both present and future, and
conducts periodic review of the program
for the purposes of determining and
advising on the scientific merit of its
activities and their overall scientific
quality. Its members are selected from
recognized authorities knowledgeable in
fields such as toxicology, pharmacology,
pathology, biochemistry, epidemiology,
risk assessment, carcinogenesis,
mutagenesis, molecular biology,
behavioral toxicology and
neurotoxicology, immunotoxicology,
reproductive toxicology or teratology,
and biostatistics. Members serve
overlapping terms of up to four years.
NTP BSC meetings are held annually or
biannually.
pwalker on PROD1PC71 with NOTICES
Dated: May 3, 2007.
Samuel H. Wilson,
Deputy Director, National Institute of
Environmental Health Sciences and National
Toxicology Program.
[FR Doc. E7–9174 Filed 5–11–07; 8:45 am]
BILLING CODE 4140–01–P
VerDate Aug<31>2005
18:21 May 11, 2007
Jkt 211001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
27135
May 7, 2007.
Carolyn M. Clancy,
Director.
[FR Doc. 07–2365 Filed 5–11–07; 8:45am]
BILLING CODE 4160–90–M
Notice of Meeting
In accordance with section 10(d) of
the Federal Advisory Committee Act (5
U.S.C., Appendix 2), announcement is
made of a Health Care Policy and
Research Special Emphasis Panel (SEP)
meeting.
A Special Emphasis Panel is a group
of experts in fields related to health care
research who are invited by the Agency
for Healthcare Research and Quality
(AHRQ), and agree to be available, to
conduct on an a needed basis, scientific
reviews of applications of AHRQ
support. Individual members of the
Panel do not attend regularly-scheduled
meetings and do not serve for fixed
terms or a long period of time. Rather,
they are asked to participate in
particular review meetings which
require their type of expertise.
Substantial segments of the upcoming
SEP meeting listed below will be closed
to the public in accordance with the
Federal Advisory Committee Act,
section 10(d) of 5 U.S.C., Appendix 2
and 5 U.S.C. 552b(c)(6). Grant
applications for Ambulatory Safety and
Quality: ‘‘Enabling Patient-Centered
Care through Health IT (R18),’’ are to be
reviewed and discussed at this meeting.
These discussions are likely to reveal
personal information concerning
individuals associated with the
applications. This information is
exempt from mandatory disclosure
under the above-cited statutes.
SEP Meeting on: Ambulatory Safety
and Quality: Enabling Patient-Centered
Care through Health IT (R18).
Date: June 14–15, 2007 (Open on July
14 from 8 a.m. to 8:15 a.m. and closed
for the remainder of the meeting).
Place: Hilton Washington DC/
Rockville Executive Meeting (Formerly
the Doubletree Hotel), 1750 Rockville
Pike, Rockville, Maryland 20852.
Contact Person: Anyone wishing to
obtain a roster of members, agenda or
minutes of the non-confidential portions
of this meeting should contact Mrs.
Bonnie Campbell, Committee
Management Officer, Office of
Extramural Research, Education and
Priority Populations, AHRQ, 540
Gaither Road, Room 2038, Rockville,
Maryland 20850, Telephone (301) 427–
1554.
Agenda items for this meeting are
subject to change as priorities dictate.
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2007N–0053]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Food Labeling
Regulations
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by June 13,
2007.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–6974. All comments should be
identified with the OMB control number
0910–0381. Also include the FDA
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT:
Jonna Capezzuto, Office of the Chief
Information Officer (HFA–250), Food
and Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857, 301–827–
4659.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
Food Labeling Regulations (OMB
Control Number 0910–0381)—Extension
FDA regulations require food
producers to disclose to consumers and
others specific information about
themselves or their products on the
label or labeling of their products.
Related regulations require that food
producers retain records establishing
the basis for the information contained
in the label or labeling of their products
and provide those records to regulatory
E:\FR\FM\14MYN1.SGM
14MYN1
]]>Agencies
[Federal Register Volume 72, Number 92 (Monday, May 14, 2007)]
[Notices]
[Page 27135]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-2365]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Notice of Meeting
In accordance with section 10(d) of the Federal Advisory Committee
Act (5 U.S.C., Appendix 2), announcement is made of a Health Care
Policy and Research Special Emphasis Panel (SEP) meeting.
A Special Emphasis Panel is a group of experts in fields related to
health care research who are invited by the Agency for Healthcare
Research and Quality (AHRQ), and agree to be available, to conduct on
an a needed basis, scientific reviews of applications of AHRQ support.
Individual members of the Panel do not attend regularly-scheduled
meetings and do not serve for fixed terms or a long period of time.
Rather, they are asked to participate in particular review meetings
which require their type of expertise.
Substantial segments of the upcoming SEP meeting listed below will
be closed to the public in accordance with the Federal Advisory
Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C.
552b(c)(6). Grant applications for Ambulatory Safety and Quality:
``Enabling Patient-Centered Care through Health IT (R18),'' are to be
reviewed and discussed at this meeting. These discussions are likely to
reveal personal information concerning individuals associated with the
applications. This information is exempt from mandatory disclosure
under the above-cited statutes.
SEP Meeting on: Ambulatory Safety and Quality: Enabling Patient-
Centered Care through Health IT (R18).
Date: June 14-15, 2007 (Open on July 14 from 8 a.m. to 8:15 a.m.
and closed for the remainder of the meeting).
Place: Hilton Washington DC/Rockville Executive Meeting (Formerly
the Doubletree Hotel), 1750 Rockville Pike, Rockville, Maryland 20852.
Contact Person: Anyone wishing to obtain a roster of members,
agenda or minutes of the non-confidential portions of this meeting
should contact Mrs. Bonnie Campbell, Committee Management Officer,
Office of Extramural Research, Education and Priority Populations,
AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, Telephone
(301) 427-1554.
Agenda items for this meeting are subject to change as priorities
dictate.
May 7, 2007.
Carolyn M. Clancy,
Director.
[FR Doc. 07-2365 Filed 5-11-07; 8:45am]
BILLING CODE 4160-90-M
